Ablynx is granted GLP certificate for new GLP unit
Having received this GLP certificate, Ablynx's GLP unit will be able to seamlessly carry out pre-clinical analytical testing and pharmacokinetics studies in-house, to the required regulatory standard.
Dr Edwin Moses, CEO and Chairman of Ablynx, commented: "Being awarded the GLP certificate from the Belgian authorities confirms our commitment to consistently perform at a high standard in this stringent regulatory environment. This is an important milestone for Ablynx as we continue to grow towards a product-based company. With this certificate, we no longer solely rely on third parties to carry out the pre-clinical GLP testing for our programmes. This enables us to retain more control on quality, timing and associated costs."
Most read news
Other news from the department politics & laws
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.